Causality was assessed with the Naranjo scale, which calculated a score of four, indicating a possible drug reaction (Table 2) [9]
Most providers avoid this concentration for higher doses because of the large injection volumes involved
For patients reducing other diabetes medications as Retatrutide takes effect, more frequent monitoring prevents unexpected highs or lows
Philipose, et al., 'Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial', N
In contrast, therapies such as GLP-1 receptor agonists and certain MRAs are more appropriately initiated in the outpatient setting, where longitudinal follow-up and dose titration can be safely achieved
Its time for a new conversation